Background gradient

ESR1m Educational Webinar:
Integrating ESR1m Testing into HR+/HER2− Metastatic Breast Cancer Care

27.08.2026

18:00 – 19:30 SGT  (Singapore)
14:00 – 15:30 GST  (Dubai/UAE)
12:00 –13:30 CEST (Central Europe)

MphaR Virtual Platform

As the understanding of ESR1 mutations (ESR1m) continuesto evolve, integrating molecular testing into clinical decision-making isbecoming increasingly important in the management of HR+/HER2− metastaticbreast cancer.This educational webinar aims to provide practical insights intocurrent evidence, testing approaches, and real-world considerations forimplementing ESR1m testing in routine practice.

Meeting Objectives:

  • Review the evolving evidence onESR1m in HR+/HER2- metastatic breast cancer management.
  • Discuss practicalconsiderations for ESR1m testing, particularly ctDNA monitoring, inHR+/HER2- metastatic breast cancer.
  • Optimize evidence-basedapproaches for integrating ESR1m serial monitoring into clinicalpractice in HR+/HER2- metastatic breast cancer

Abbreviations: ctDNA, circulating tumor DNA;ESR1, estrogen receptor 1; ESR1m, estrogen receptor 1 mutation(s); HR+/HER2−,hormone receptor-positive/human epidermal growth factor receptor 2-negative


Registration

If you are interested in joining this Educational Webinar, please complete the form below and click the “Register” button to secure your place.
Once your registration is complete, you will receive a confirmation email with further details, including Virtual Platform access information and next steps.

Attendee Information

Profile Information

Consent

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Thank you! Your registration has been confirmed. We look forward to your participation. You will soon receive additional information, including instructions on how to access the platform and join the webinar. If you have any questions, please contact us at virtualplatform@m-phar.com.

Proprietary and confidential © AstraZeneca 2026. Not for further distribution.This Educational Webinar is organized and funded by AstraZeneca for invited healthcare professionals (HCPs) only.

VEEVA ID: ZX-XXXX | DOP: July 2026

Footer Logos